# EDGAR Filing Document

**Accession Number:** 0001868995
**File Stem:** 0001554855-23-000153
**Filing Date:** 2023-3
**Character Count:** 34842
**Document Hash:** fc4b42550b0f6212b0d41b065067c0b2
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001554855-23-000153.hdr.sgml**: 20230308

**ACCESSION NUMBER**: 0001554855-23-000153

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20230308

**FILED AS OF DATE**: 20230308

**DATE AS OF CHANGE**: 20230308

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CI&T Inc
- **CENTRAL INDEX KEY:** 0001868995
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
- **IRS NUMBER:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-41035
- **FILM NUMBER:** 23714817

**BUSINESS ADDRESS:**
- **STREET 1:** PO BOX 309
- **CITY:** UGLAND HOUSE - GRAND CAYMAN
- **STATE:** E9
- **ZIP:** KY1-1104
- **BUSINESS PHONE:** 55 (19) 21023859

**MAIL ADDRESS:**
- **STREET 1:** RUA DOUTOR RICARDO BENETTON MARTINS 1000
- **STREET 2:** POLIS DE TECNOLOGIA - PRISMA BUILDING
- **CITY:** CAMPINAS
- **STATE:** D5
- **ZIP:** 13086-902

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

&nbsp;&nbsp; **Form 6-K**<br>

**REPORT OF FOREIGN PRIVATE ISSUER**

**PURSUANT TO RULE 13A-16 OR 15D-16**

**UNDERTHE SECURITIES EXCHANGE ACT OF 1934**

For the month of March 2022

Commission File Number: 001-41035

**CI&T Inc**

(Translation of registrant's name into English)

**Estrada Guiseppina Vianelli De Napoli, 1455 – C,** 

**Globaltech 13.100-000 - Brazil**

**Campinas-State of São Paulo**

**+55 19 21024500**

(Address of principal executive office))

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ____<u>X</u>____ Form 40-F ________

------

[**Table of Contents**](#TOC) <br>

**CI&T Inc**

**TABLE OF CONTENTS**

ITEM

[1. 4Q22 Earnings Release](#BA_YY2VB74PA800000000000000000000)

------

[**Table of Contents**](#TOC)

[**CI&T Reports Strong Fourth Quarter and Full-year 2022 Results**](#TOC)

**New York - March 8, 2023** /Business Wire/ - CI&T (NYSE: CINT, "Company"), a global digital specialist, today announces its results for the fourth quarter of 2022 (4Q22), and the full-year ended on December 31, 2022 (2022) in accordance with International Financial Reporting Standards (IFRS). For comparison purposes, we refer to the results for the fourth quarter of 2021 (4Q21) and the full-year ended on December 31, 2021 (2021).

**Fourth Quarter of 2022 Operating and Financial Highlights**

● Net Revenue was R$611.8 million, an increase of 33.9% compared to 4Q21 or a 41.5% growth at constant currency.

● The number of clients with annual revenue above R$1 million in the last twelve months grew from 94 in 4Q21 to 178 in 4Q22.

● Net Profit was R$30.1 million compared to R$43.8 million in 4Q21.

● Adjusted EBITDA was R$127.4 million, a 25.1% growth year-over-year, equivalent to an Adjusted EBITDA margin of 20.8%.

● Adjusted Net Profit was R$54.5 million, 4.3% higher than 4Q21 with an Adjusted Net Profit margin of 8.9%

**Full-year ended December 31, 2022 Operating and Financial Highlights**

****

<br> ● Net Revenue was R$2,187.7 million, an increase of 51.5% compared to 2021, or a 57.9% growth at constant currency.

● Net Profit was R$125.9 million, compared to R$125.9 million in 2021.

● Adjusted EBITDA was R$417.5 million, 28.8% higher than 2021, with an Adjusted EBITDA margin of 19.1%.

● Adjusted Net Profit was R$213.6 million, an increase of 30.2% compared to 2021.

● CI&T ended 2022 with 6,904 employees, a 24.1% growth compared to the end of 2021.

Cesar Gon, founder and CEO of CI&T, commented, "Our core competency is method-driven innovation for large and fast-growing corporations, and we are obsessed with efficiency for our clients and ourselves. We ended 2022 marking our 28th consecutive year of profitable growth, highlighting a net revenue expansion of 51% year-over-year and the addition of 84 new clients.

**Comments on the 4Q22 financial performance**

The net revenue was R$611.8 million in 4Q22, an increase of 33.9% compared to 4Q21, or a 41.5% net revenue growth at constant currency. In 4Q22, we added 31 new clients to our portfolio with annual revenue above R$1.0 million in the last twelve months, increasing our client base from 147 in 3Q22 to 178 in 4Q22. The net revenue grew in all regions and industry verticals that we operate compared to the same period last year.

------

[**Table of Contents**](#TOC)

The cost of services provided in 4Q22 reached R$391.1 million, an increase of 32.7% in relation to 4Q21, and the gross profit was R$220.7 million. The Adjusted Gross Profit in 4Q22 was R$234.4 million, 36.0% higher than in 4Q21. The Adjusted Gross Profit margin was 38.3%, an increase of 0.6 percentage points compared to 4Q21, due to better pricing, despite the lower gross margins from the acquired companies.

In 4Q22, selling, general and administrative (SG&A), and other operating expenses were R$134.2 million, 61.3% higher when compared to 4Q21, mainly due to (i) an increase in personnel expenses, as a result of new hirings in the back-office areas; and (ii) acquisition-related expenses, such as retention packages, fair value adjustments on account payable for business combination, and amortization of intangible assets from the acquired companies.

In 4Q22, the Adjusted EBITDA was R$127.4 million, an increase of 25.1% compared to 4Q21. Adjusted EBITDA margin was 20.8% in the quarter, a reduction of 1.5 percentage point compared to 4Q21, mainly due to higher SG&A expenses. Sequentially, the Adjusted EBITDA margin improved from 19.2% in 3Q22 to 20.8% in 4Q22, due to better utilization rate and lower SG&A expenses as a percentage of revenue.

In 4Q22, net financial expenses were R$31.9 million, an increase of R$23.8 million, compared to 4Q21, mainly as a result of a net foreign exchange loss of R$15.8 million in 4Q22, compared to a net foreign exchange gain of R$9.2 million in 4Q21.

In 4Q22, income tax expense was R$24.5 million, a reduction of 9% in relation to 4Q21. Depreciation and amortization expenses totaled R$27.4 million in 4Q22, an increase of 50.2% or R$9.1 million compared to 4Q21, due to the amortization from intangible assets from acquired companies in the amount of R$13.8 million. In 4Q22, management reduced its real state property leases based on the successful work-from-anywhere approach, which will contribute to lower leases expenses going forward.

In 4Q22, the net profit was R$30.1 million, compared to a net profit of R$43.8 million in 4Q21. Adjusted Net Profit was R$54.5 million, 4.3% higher than 4Q21. The Adjusted Net Profit margin reduced from 11.4% in 4Q21 to 8.9% in 4Q22, mainly due to an increase in SG&A expenses and the foreign exchange variation in the comparable period, as detailed above.

**Comments on the 2022 financial performance**

The net revenue in 2022 was R$2,187.7 million, an increase of 51.5% compared to 2021. The contribution from the companies acquired in 2022 was 15 percentage points to the revenue growth. The negative foreign currency translation impact was 6.4% in the period and the net revenue growth at constant currency was 57.9%.

------

[**Table of Contents**](#TOC) <br>

During 2022, CI&T added 84 new clients with annual revenue above R$1.0 million to our portfolio, demonstrating CI&T's capability to onboard new clients and the resilience in the demand for digital services.

The cost of services provided in 2022 reached R$1,425.2 million, an increase of 52.3% in relation to 2021, and the gross profit was R$762.5 million. The Adjusted Gross Profit in 2022 was R$807.7 million, 48.9% higher than in 2021. The Adjusted Gross Profit margin was 36.9%, a slight decrease compared to 37.6% in 2021, mainly due to lower margins from the acquired companies.

In 2022, selling, general and administrative (SG&A), and other operating expenses were R$488.6 million, an increase of 85.0% when compared to 2021, mainly due to (i) the strengthening of our back-office teams as a publicly-listed Company, and (ii) acquisition-related expenses, such as retention packages, consulting expenses, and amortization of intangible assets from acquired companies.

In 2022, the Adjusted EBITDA was R$417.5 million, an increase of 28.8% compared to 2021. Adjusted EBITDA margin was 19.1% in the year, a reduction of 3.3 percentage points compared to 2021, mainly explained by the lower gross margin and the increase in SG&A expenses, as detailed above.

In 2022, net financial expenses were R$73.6 million, 115.1% higher compared to 2021, as a result of an increase in the debt position and higher interest rates.

In 2022, depreciation and amortization expenses totaled R$94.6 million, an increase of 95.6% or R$46.2 million compared to 2021, of which R$43.1 million are related to the amortization of intangible assets from acquired companies.

In 2022, income tax expense was R$74.4 million, a reduction of 11.9% in relation to 2021. The income tax paid (cash effect) was R$48.3 million in the period, equivalent to a cash tax rate of 24%.

In 2022, the net profit was R$125.9 million, in line with the net profit recorded in 2021. Adjusted Net Profit was R$213.6 million, 30.2% higher than 2021. The Adjusted Net Profit margin was 9.8% in 2022, a reduction of 1.6 percentage points compared to 2021, mainly due to higher SG&A and financial expenses, as detailed above.

In 2022, cash generated from operating activities net of taxes were R$112.4 million, which is reduced by a cash outflow of R$59.7 million for the operating activities of the acquiree Somo and other acquisition related expenses. If we exclude these impacts, the cash generated from operating activities net of taxes would have been R$172.1 million in 2022.

The cash and cash equivalents position, including financial investments, were R$282.0 million at the end of 2022. Loans and borrowings totaled R$974.2 million in 2022, compared to R$788.7 million in 2021. The incremental debt position was mainly to finance the NTERSOL acquisition.

------

[**Table of Contents**](#TOC)

**Business Outlook**

****

<br> We expect our net revenue in the first quarter of 2023 to be at least R$590 million compared to a net revenue of R$492 million in the first quarter of 2022, a 20% growth on a reported basis.

For the full year of 2023, we expect net revenue growth in the range of 13% to 17% year-over-year, assuming a constant currency outlook.

In addition, we estimate our Adjusted EBITDA margin to be at least 19% for the full year of 2023.

These expectations are forward-looking statements and actual results may differ materially. See "Cautionary Statement on Forward-Looking Statements" below.

**Conference Call Information**

****

<br> Cesar Gon, Bruno Guicardi, Stanley Rodrigues, and Eduardo Galvão will host a video conference call to discuss the 4Q22 and 2022 financial and operating results on March 08, at 8:00 a.m. Eastern Time / 10:00 a.m. BRT. The earnings call can be accessed at the Company's Investor Relations website at <u>https://investors.ciandt.com</u> or at the following link: <u>https://www.youtube.com/watch?v=80LiTtgxwd4</u>

****

<br> **About CI&T**

****

<br> CI&T (NYSE:CINT) is a global digital specialist, a partner in digital transformation for 100+ large enterprises and fast growth clients. As digital natives, CI&T brings a 28-year track record of accelerating business impact through complete and scalable digital solutions. With a global presence in nine countries with a nearshore delivery model, CI&T provides strategy, data science, design, and engineering, unlocking top-line growth, improving customer experience and driving operational efficiency. Recognized by Forrester as a Leader in Modern Application Development Services, CI&T is the Employer of Choice for more than 6,900 professionals.

**Basis of accounting and functional currency**

CI&T maintains its books and records in Brazilian *reais*, the presentation currency for its audited consolidated financial statements, and the functional currency of our operations in Brazil. CI&T prepares its audited consolidated financial statements in accordance with IFRS, as issued by the IASB.

------

[**Table of Contents**](#TOC)

**Non-IFRS Financial Measures**

****

<br> We regularly monitor certain financial and operating metrics to evaluate our business, measure our performance, identify trends affecting our business, formulate financial projections and make strategic decisions. These non-IFRS financial measures include Adjusted Gross Profit, Adjusted Gross Profit Margin, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Net Profit, Adjusted Net Profit Margin, Net Revenue at Constant Currency, and Net Revenue Growth at Constant Currency, and should be considered in addition to results prepared in accordance with IFRS, but not as substitutes for IFRS results. In addition, our calculation of these non-IFRS financial measures may differ from those used by other companies, and therefore comparability may be limited. These non-IFRS financial measures are provided as additional information to enhance investors' overall understanding of our operations' historical and current financial performance.

CI&T is not providing a quantitative reconciliation of forward-looking Non-IFRS Net Revenue Growth at Constant Currency and Adjusted EBITDA to the most directly comparable IFRS measure because it is unable to reasonably predict the ultimate outcome of certain significant items without unreasonable efforts. These items include, but are not limited to, stock-based compensation expenses, acquisition-related expenses, the tax effect of non-IFRS adjustments, foreign currency exchange (gains)/losses, and other items. These items are uncertain, depend on various factors, and could have a material impact on IFRS reported results for the guidance period.

We calculate Net Revenue at Constant Currency and Net Revenue Growth at Constant Currency by translating Net revenue from entities reporting in foreign currencies into Brazilian *reais* using the comparable foreign currency exchange average rates from the prior period to show changes in our revenue without giving effect to period-to-period currency fluctuations. Reported Net Revenue in 2022 considers the FX rate at the end of each month, while Net Revenue at Constant Currency considers the average FX rate for the prior period.

In calculating Adjusted Gross Profit, we exclude cost components unrelated to the direct management of our services. For the periods herein, the adjustments applied were: (i) depreciation and amortization related to costs of services provided; and (ii) stock-based compensation expenses.

In calculating Adjusted EBITDA, we exclude components unrelated to the direct management of our services. For the periods herein, the adjustments were: (i) stock-based compensation expenses; (ii) consulting expenses related to the initial public offering and corporate reorganization; (iii) government grants related to tax reimbursement in the Chinese subsidiary; (iv) non-cash expenses related to the impairment associated with the discontinuation of certain investments made by Dextra on intangible assets related to digital platforms; and (v) acquisition-related expenses, including fair value adjustment on accounts payable for business combination, consulting expenses, and retention package.

In calculating Adjusted Net Profit, we exclude components unrelated to the direct management of our services. For the periods herein, the adjustments applied were: (i) consulting expenses related to the initial public offering and corporate reorganization, (ii) non-cash expenses related to the impairment associated with the discontinuation of certain investments made by Dextra on intangible assets related to digital platforms; and (iii) acquisition-related expenses, including amortization of intangible assets from acquired companies, fair value adjustment on accounts payable for business combination, consulting expenses, and retention packages.

------

[**Table of Contents**](#TOC)

**Cautionary Statement on Forward-Looking Statements**

This press release includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, which include but are not limited to: the statements under "Business outlook," including expectations relating to revenues and other financial or business metrics; statements regarding relationships with clients; and any other statements of expectation or belief. The words "believe," "will," "may," "may have," "would," "estimate," "continues," "anticipates," "intends," "plans," "expects," "budget," "scheduled," "forecasts" and similar words are intended to identify estimates and forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements represent our management's beliefs and assumptions only as of the date of this press release. You should read this press release with the understanding that our actual future results may be materially different from what we expect. These statements are subject to known and unknown risks, uncertainties, and other factors that may cause our actual results, levels of activity, performance, or achievements to differ materially from results expressed or implied in this press release. Such risk factors include, but are not limited to, those related to: the current and future impact of the COVID-19 pandemic, the ongoing war in Ukraine and economic sanctions imposed by Western economies over Russia on our business and industry; the effects of competition on our business; uncertainty regarding the demand for and market utilization of our services; the ability to maintain or acquire new client relationships; general business and economic conditions; our ability to successfully integrate the recent acquired companies; and our ability to successfully execute our growth strategy and strategic plans. Additional information concerning these and other risks and uncertainties are contained in the "Risk Factors" section of CI&T's annual report on Form 20-F. Additional information will be made available in our annual reports on Form 20-F, and other filings and reports that CI&T may file from time to time with the SEC. Except as required by law, CI&T assumes no obligation and does not intend to update these forward-looking statements or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

**Contacts:**

**Investor Relations Contact:**

Eduardo Galvão

investors@ciandt.com

**Media Relations Contact:**

Zella Panossian

ciandt@illumepr

------

[**Table of Contents**](#TOC)

**Consolidated statement of profit or loss**

(In thousands of Brazilian Reais)

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | **Quarter ended December 31,**  | **Quarter ended December 31,**  | **Full year ended December 31,**  | **Full year ended December 31,**  |
|  | **2022** | **2021** | **2022** | **2021** |
| **Net Revenue**  | **611805** | **456794** | **2187710** | **1444380** |
| Costs of services provided  | (391108 ) | (294746 ) | (1425219 ) | (935732 ) |
| **Gross Profit**  | **220697** | **162048** | **762491** | **508648** |
| Selling expenses  | (45443 ) | (27752 ) | (163871 ) | (89654 ) |
| General and administrative expenses  | (87800 ) | (58625 ) | (315915 ) | (151681 ) |
| Research and technological innovation expenses  | -  | -  | -  | (4 ) |
| Impairment loss on trade receivables and contract assets  | 56 | 1533 | (329 ) | (497 ) |
| Other income (expenses) net  | (966 ) | 1656 | (8458 ) | (22206 ) |
| **Operating profit before financial income and tax**  | **86544** | **78860** | **273918** | **244606** |
| Finance income  | 17358 | 26395 | 172996 | 69816 |
| Finance cost  | (49327 ) | (34525 ) | (246642 ) | (104048 ) |
| **Net finance costs**  | **(31969)** | **(8130)** | **(73646)** | **(34232)** |
| **Profit before Income tax**  | **54575** | **70730** | **200272** | **210374** |
| Income tax expense  |  |  |  |  |
| Current  | (25077 ) | (32008 ) | (69873 ) | (95375 ) |
| Deferred  | 588 | 5106 | (4483 ) | 10958 |
| **Net profit for the period**  | **30086** | **43828** | **125916** | **125957** |
| **Earnings per share**  |  |  |  |  |
| Earnings per share – basic (in R$)  |  |  | 0.95 | 1.03 |
| Earnings per share – diluted (in R$)  |  |  | 0.93 | 1.01 |
| Weighted average number of basic shares held by shareholders  |  |  | 133186441 | 121777128 |
| Weighted average number of diluted shares held by shareholder  |  |  | 134774674 | 125155798 |

---

------

[**Table of Contents**](#TOC)

**Consolidated statements of financial position** 

(In thousands of Brazilian Reais)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Assets**  | **December 31, 2022**  | **December 31, 2021**  | **Liabilities and equity**  | **December 31, 2022**  | **December 31, 2021**  |
| Cash and cash equivalents  | 185727 | 135727 | Suppliers and other payables  | 33376 | 33566 |
| Financial Investments  | 96299 | 798786 | Loans and borrowings  | 231296 | 164403 |
| Trade receivables  | 501671 | 340519 | Lease liabilities  | 21539 | 21214 |
| Contract assets  | 217250 | 134388 | Salaries and welfare charges  | 260156 | 234173 |
| Recoverable taxes  | 7619 | 7785 | Accounts payable for business combination  | 71650 | 48923 |
| Tax assets  | 2959 | 2810 | Derivatives - hedge accounting  | 35169 | -  |
| Derivatives - hedge accounting  | 19637 | -  | Derivatives  | 4109 | 535 |
| Derivatives  | 11194 | 896 | Tax liabilities  | 3890 | 13345 |
| Other assets  | 38269 | 29994 | Other taxes payable  | 14382 | 5423 |
| **Total current assets**  | **1080625** | **1450905** | Contract liability  | 32136 | 13722 |
|  |  |  | Other liabilities  | 47501 | 13669 |
| Recoverable taxes  | 3624 | 3046 | **Total current liabilities**  | **755204** | **548973** |
| Deferred tax assets  | 35138 | 31989 |  |  |  |
| Judicial deposits  | 9819 | 3079 | Loans and borrowings  | 742935 | 624306 |
| Restricted cash - Escrow account and indemnity asset  | 31552 | -  | Lease liabilities  | 41269 | 60674 |
| Other assets  | 3654 | 2974 | Provisions  | 12347 | 633 |
| Property, plant and equipment  | 55266 | 57721 | Accounts payable for business combination  | 133299 | 36803 |
| Intangible assets and goodwill  | 1750898 | 738803 | Other liabilities  | 3530 | 1660 |
| Right-of-use assets  | 56187 | 73827 | **Total non-current liabilities**  | **933380** | **724076** |
| **Total non-current assets**  | **1946138** | **911439** |  |  |  |
|  |  |  | **Equity**  |  |  |
|  |  |  | Share capital  | 37 | 36 |
|  |  |  | Share premium  | 946173 | 915947 |
|  |  |  | Capital reserves  | 203218 | 10105 |
|  |  |  | Profit reserves  | 251873 | 125957 |
|  |  |  | Other comprehensive income (loss)  | (63122 ) | 37250 |
|  |  |  | **Total equity**  | **1338179** | **1089295** |
| **Total assets**  | **3026763** | **2362344** | **Total equity and liabilities**  | **3026763** | **2362344** |

---

------

[**Table of Contents**](#TOC)

**Consolidated statement of cash flow** 

(In thousands of Brazilian Reais)

---

| | | |
|:---|:---|:---|
|  | **December 31, 2022**  | **December 31, 2021**  |
| Net profit for the period  | 125916 | 125957 |
|  ***Adjustments for:***  |  |  |
| Depreciation and amortization  | 94558 | 48354 |
| Loss on the sale of property, plant and equipment and intangible assets  | 3781 | 1237 |
| Interest, monetary variation and exchange rate changes  | 55323 | 45627 |
| Interest and exchange variation on accounts payable for business combinations  | (2994 ) | 3091 |
| Exchange variation on escrow account related to Somo acquisition  | 2968 | -  |
| Interest on lease  | 3823 | 6369 |
| Unrealized loss (gain) on financial instruments  | (7114 ) | 3084 |
| Income tax expenses  | 74356 | 84417 |
| Impairment losses on trade receivables  | 423 | 280 |
| (Reversal of) impairment losses on contract assets  | (94 ) | 217 |
| Write-off of intangible assets  | -  | 21894 |
| Provision for labor risks  | 386 | 472 |
| Share-based plan  | 5486 | 2531 |
| Income on financial investments  | (1964 ) | -  |
| Fair value adjustment - accounts payable for business combination  | 11497 | -  |
| Others  | (1855 ) | 98 |
| **Variation in operating assets and liabilities**  |  |  |
| Trade receivables  | (116574 ) | (102300 ) |
| Contract assets  | (69101 ) | (52876 ) |
| Other taxes recoverable  | (547 ) | (13806 ) |
| Tax assets  | 1267 | (91 ) |
| Judicial deposits  | (6741 ) | 4 |
| Suppliers  | (29769 ) | 12215 |
| Salaries and welfare charges  | 10729 | 63083 |
| Tax liabilities  | (9681 ) | (17364 ) |
| Other taxes payable  | 6376 | 1698 |
| Contract liabilities  | 9636 | 1922 |
| Payment of share-based indemnity  | -  | (628 ) |
| Other receivables and payables, net  | 565 | (21054 ) |
| **Cash generated from operating activities**  | **160656** | **214431** |
| Income tax paid  | (48299 ) | (64150 ) |
| Interest paid on loans and borrowings  | (70096 ) | (12149 ) |
| Interest paid on lease  | (6169 ) | (5753 ) |
| **Net cash from operating activities**  | **36092** | **132379** |
| **Cash flows from investment activities:**  |  |  |
| Acquisition of property, plant and equipment and intangible assets  | (22967 ) | (29907 ) |
| Acquisition of subsidiary net of cash acquired – Dextra  | -  | (692722 ) |
| Acquisition of subsidiary net of cash acquired - Somo  | (270825 ) | -  |
| Acquisition of subsidiary net of cash acquired - Box 1824  | (19040 ) | -  |
| Acquisition of subsidiary net of cash acquired - Transpire  | (55724 ) | -  |
| Acquisition of subsidiary net of cash acquired - Ntersol  | (400137 ) | -  |
| Cash outflow on hedge accounting settlement  | 25263 |  |
| Hedge accounting - ineffective portion inflow  | 5337 | -  |
| Redemption (Contribution in) of financial investments  | 655533 | (784915 ) |
| **Net cash used in investment activities**  | **(82560)** | **(1507544)** |
| **Cash flow from financing activities:**  |  |  |
| Share-based plan contributions  | -  | 1282 |
| Issuance of common shares at initial public offering  | -  | 915947 |
| Transaction cost of offering  | -  | (55874 ) |
| Dividends paid  | -  | (126045 ) |
| Exercised stock options  | 12668 | -  |
| Interest on equity, paid  | -  | (6288 ) |
| Payment of lease liabilities  | (26993 ) | (17656 ) |
| Proceeds from loans and borrowings  | 527507 | 740596 |
| Settlement of derivatives  | 390 | -  |
| Payment of loans and borrowings  | (350571 ) | (75196 ) |
| Payment of installment related to acquisition of business - Dextra  | (62338 ) | -  |
| **Net cash from financing activities**  | **100663** | **1376766** |
| **Net increase in cash and cash equivalents**  | **54195** | **1601** |
| Cash and cash equivalents as of January 1st | 135727 | 162827 |
| Exchange variation effect on cash and cash equivalents  | (4195 ) | (20949 ) |
| Cash reduction due to spin-off effect  | -  | (7752 ) |
| **Cash and cash equivalents as of December**  | **185727** | **135727** |

---

------

[**Table of Contents**](#TOC)

**Reconciliation of Non-IFRS financial measures to comparable IFRS financial measures**

Reconciliation of revenue growth as reported on a IFRS basis to revenue growth on a constant currency basis:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Net Revenue (in BRL thousand)**  | **4Q22**  | **4Q21**  | **Var. 4Q22 x 4Q21**  | **2022** | **2021** | **Var. 2022 x 2021**  |
| Net Revenue  | 611805 | 456794 | 33.9%  | 2187710 | 1444380 | 51.5%  |
| Net Revenue at Constant Currency  | 644956 | 455712 | 41.5%  | 2277958 | 1442539 | 57.9%  |

---

**Revenue Breakdown**

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Net Revenue by industry (in BRL thousand)**  | **4Q22**  | **4Q21**  | **Var. 4Q22 x 4Q21**  | **2022** | **2021** | **Var. 2022 x 2021**  |
| Financial Services  | 172916 | 142104 | 21.7%  | 649166 | 487177 | 33.3%  |
| Food and Beverages  | 112132 | 90283 | 24.2%  | 429023 | 340709 | 25.9%  |
| Technology, Media and Telecom  | 72463 | 67268 | 7.7%  | 328500 | 169311 | 94.0%  |
| Pharmaceuticals and Cosmetics  | 113348 | 61305 | 84.9%  | 281300 | 206375 | 36.3%  |
| Retail and Manufacturing  | 35759 | 34555 | 3.5%  | 135566 | 93871 | 44.4%  |
| Education and Services  | 22944 | 22176 | 3.5%  | 78452 | 64336 | 21.9%  |
| Logistic and Transportation  | 18387 | 16380 | 12.3%  | 73248 | 37247 | 96.7%  |
| Others  | 63856 | 22723 | 181.0%  | 212454 | 45353 | 368.4%  |
| **Total**  | **611805** | **456794** | **33.9%**  | **2187710** | **1444380** | **51.5%**  |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Net Revenue by geography (in BRL thousand)**  | **4Q22**  | **4Q21**  | **Var. 4Q22 x 4Q21**  | **2022** | **2021** | **Var. 2022 x 2021**  |
| North America  | 267233 | 200014 | 33.6%  | 923174 | 664858 | 38.9%  |
| Europe  | 63182 | 10807 | 484.6%  | 205992 | 28148 | 631.8%  |
| LATAM (Latin America)  | 251466 | 229681 | 9.5%  | 975948 | 701206 | 39.2%  |
| APJ (Asia, Pacific and Japan)  | 29923 | 16293 | 83.7%  | 82596 | 50168 | 64.6%  |

---

------

[**Table of Contents**](#TOC)

Reconciliation of various income statement amounts from IFRS to non-IFRS for the three months and full year ended December 31, 2022 and 2021:

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Gross Profit (in BRL thousand)**  | **4Q22**  | **4Q21**  | **Var. 4Q22 x 4Q21**  | **2022** | **2021** | **Var. 2022 x 2021**  |
| Net Revenue  | 611805 | 456794 | 33.9%  | 2187710 | 1444380 | 51.5%  |
| Cost of Services  | (391108 ) | (294746 ) | 32.7%  | (1425219 ) | (935732 ) | 52.3%  |
| **Gross Profit**  | **220697** | **162048** | **36.2%**  | **762491** | **508648** | **49.9%**  |
| *Adjustments*  |  |  |  |  |  |  |
| Depreciation and amortization (cost of services provided)  | 10667 | 8764 | 21.7%  | 40968 | 31884 | 28.5%  |
| Stock-based compensation  | 3045 | 1582 | 92.5%  | 4235 | 1930 | 119.4%  |
| **Adjusted Gross Profit**  | **234409** | **172394** | **36.0%**  | **807694** | **542462** | **48.9%**  |
| **Adjusted Gross Profit Margin**  | **38.3%**  | **37.7%**  | **0.6p.p**  | **36.9%**  | **37.6%**  | **-0.6p.p**  |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Adjusted EBITDA (in BRL thousand)**  | **4Q22**  | **4Q21**  | **Var. 4Q22 x 4Q21**  | **2022** | **2021** | **Var. 2022 x 2021**  |
| Net profit for the period  | 30086 | 43828 | -31.4%  | 125916 | 125957 | 0.0%  |
| *Adjustments*  |  |  |  |  |  |  |
| Net financial cost  | 31969 | 8130 | 293.2%  | 73646 | 34232 | 115.1%  |
| Income tax expense  | 24489 | 26902 | -9.0%  | 74356 | 84417 | -11.9%  |
| Depreciation and amortization  | 27404 | 18251 | 50.2%  | 94558 | 48354 | 95.6%  |
| Stock-based compensation  | 3592 | 1838 | 95.4%  | 5486 | 2531 | 116.8%  |
| Consulting expenses <sup>(1)</sup> | -  | (859 ) | -100.0%  | -  | 2220 | -100.0%  |
| Government grants  | (764 ) | (1063 ) | -28.2%  | (1141 ) | (2481 ) | -54.0%  |
| Impairment (2) | -  | 77 | -100.0%  | -  | 21895 | -100.0%  |
| Acquisition-related expenses(3) | 10601 | 4680 | 126.5%  | 44652 | 6957 | 541.8%  |
| **Adjusted EBITDA**  | **127377** | **101783** | **25.1%**  | **417472** | **324081** | **28.8%**  |
| **Adjusted EBITDA Margin**  | **20.8%**  | **22.3%**  | **-1.5p.p**  | **19.1%**  | **22.4%**  | **-3.4p.p**  |

---

(1) IPO-related expenses, including consulting and corporate reorganization expenses.

(2) Non-cash expenses related to theimpairment of intangible assets of Dextra , acquired in August 2021 in the amount of (R$21,895) in 2021 . The following adjustments were disregarded for the full year of 2022: non-cash expenses related to the write-off due to the inventory of property, plant, and equipment in the amount of (R$1,548) in 1Q22 and tax write-off of (R$2,159) in 3Q22.

(3) Include fair value adjustment on accounts payable for business combination, consulting expenses and retention packages.

------

[**Table of Contents**](#TOC)

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
| **Net Profit (in BRL thousand)**  | **4Q22**  | **4Q21**  | **Var. 4Q22 x 4Q21**  | **2022** | **2021** | **Var. 2022 x 2021**  |
| Net profit for the period  | 30086 | 43828 | -31.4%  | 125916 | 125957 | 0.0%  |
| *Adjustments*  |  |  |  |  |  |  |
| Consulting expenses <sup>(1)</sup>  | -  | (859 ) | -100.0%  | -  | 2220 | -100.0%  |
| Impairment <sup>(2)</sup> | -  | 77 | -100.0%  | -  | 21895 | -100.0%  |
| Acquisition-related expenses (3) | 24400 | 9210 | 164.9%  | 87721 | 14062 | n.m  |
| Adjusted Net Profit <sup>(4)</sup> | **54486** | **52256** | **4.3%**  | **213637** | **164134** | **30.2%**  |
| Adjusted Net Profit Margin <sup>(4)</sup> | **8.9%**  | **11.4%**  | **-2.5p.p**  | **9.8%**  | **11.4%**  | **-1.6p.p**  |

---

(1) IPO-related expenses, including consulting and corporate reorganization expenses.

(2) Non-cash expenses related to the impairment of intangible assets of Dextra , acquired in August 2021 in the amount of (R$21,895) in 2021 . The following adjustments were disregarded for the full year of 2022: non-cash expenses related to the write-off due to the inventory of property, plant, and equipment in the amount of (R$1,548) in 1Q22 and tax write-off of (R$2,159) in 3Q22.

(3) Include amortization of intangible assets from acquired companies, fair value adjustment on accounts payable for business combination, consulting expenses and retention packages.

(4) Adjustments' amounts are gross of tax. Tax effects on non-IFRS adjustments totaled (R$1,182) in 4 Q 22 , (R$365) in 4 Q 21 , (R$3,172) in 2022 , and (R$1,935) in 2021 .

------

[**Table of Contents**](#TOC)

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: March 8, 2023

---

| | |
|:---|:---|
| **CI&T Inc** | **CI&T Inc** |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By: | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;/s/ Stanley Rodrigues |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Name: Stanley Rodrigues |
|  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Title: Chief Financial Officer |

---

<br>